xCT, also known as SLC7A11, is a key protein involved in cellular redox homeostasis and plays a vital role in regulating the intracellular levels of cystine, a precursor for the synthesis of the antioxidant glutathione (GSH). Activating xCT can have significant implications for cellular responses to oxidative stress and its associated processes. xCT activators are a class of chemicals that influence the activity of this protein, either directly or indirectly, and can impact cellular redox balance. One approach to activating xCT is through direct inhibition of the xCT protein. Compounds like Sulfasalazine and Erastin fall into this category. Sulfasalazine, for instance, inhibits cystine uptake through xCT by interfering with the cystine-glutamate antiporter, leading to reduced cystine levels in cells. This reduction affects cellular GSH synthesis and subsequently influences various cellular processes. Erastin, on the other hand, induces a type of regulated cell death known as ferroptosis by binding to and inhibiting xCT function. This inhibition curbs the uptake of cystine, a critical component for GSH synthesis, thereby compromising cellular antioxidant defenses.
Indirect xCT activators, such as Sorafenib and Curcumin, influence xCT activity through signaling pathways. Sorafenib, a kinase inhibitor, can reduce xCT expression in certain cancer cells by interfering with signaling cascades associated with cell growth and survival. Similarly, Curcumin modulates xCT expression and function indirectly by inhibiting the activation of NF-κB, a transcription factor involved in inflammation, leading to reduced xCT expression. These indirect activators, by impacting upstream signaling events, can alter xCT levels and function, ultimately affecting cellular responses to oxidative stress and redox homeostasis. In summary, xCT activators encompass a diverse group of chemicals that can either directly inhibit xCT function or indirectly influence it through modulating signaling pathways. These compounds play a pivotal role in regulating cellular responses to oxidative stress, and their mechanisms of action can impact various cellular processes related to redox homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erastin | 571203-78-6 | sc-205677 sc-205677A | 5 mg 50 mg | $365.00 $1582.00 | 1 | |
Erastin induces ferroptosis, a form of regulated cell death, by binding to and inhibiting xCT function, preventing cystine uptake, and compromising cellular antioxidant defenses. | ||||||
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $63.00 $250.00 | 13 | |
Phloretin indirectly influences xCT by inhibiting glucose transporters (GLUTs). By disrupting glucose uptake, it can lead to alterations in redox homeostasis and cellular responses that indirectly impact xCT activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin modulates xCT expression and function indirectly by inhibiting the activation of NF-κB, a transcription factor involved in inflammation, leading to reduced xCT expression. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
Gefitinib indirectly influences xCT expression by blocking EGFR signaling pathways. This interference with signaling cascades may lead to changes in xCT levels and function. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Haloperidol indirectly impacts xCT by modulating dopamine receptor signaling. Changes in dopamine receptor activity may lead to alterations in xCT expression and function. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
Indomethacin indirectly affects xCT expression by inhibiting COX (cyclooxygenase) enzymes. Alterations in COX activity can lead to changes in xCT levels and function. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Simvastatin may indirectly influence xCT expression by modulating the mevalonate pathway, impacting the prenylation of proteins involved in xCT regulation. | ||||||